Package 71335-1114-1

{"route": ["ORAL"], "spl_id": "99d9c657-4add-4f6e-8c5d-75d888473e23", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["64be3113-837a-48f3-9f9e-400529c9ee94"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-1)", "package_ndc": "71335-1114-1", "marketing_start_date": "20190222"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-2)", "package_ndc": "71335-1114-2", "marketing_start_date": "20240905"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-3)", "package_ndc": "71335-1114-3", "marketing_start_date": "20190221"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-4)", "package_ndc": "71335-1114-4", "marketing_start_date": "20190329"}, {"sample": false, "description": "8 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-5)", "package_ndc": "71335-1114-5", "marketing_start_date": "20240905"}, {"sample": false, "description": "180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-1114-6)", "package_ndc": "71335-1114-6", "marketing_start_date": "20240905"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "71335-1114_99d9c657-4add-4f6e-8c5d-75d888473e23", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-1114", "generic_name": "bupropion hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}